← Eichor
Study identifier: NCT06956729 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Multicenter Trial of Proximal Femoral Guided Growth in Children With CP and Hips at Risk of Dislocation (GGSH-MC)

Condition: Cerebral Palsy  ·  Sponsor: Fundación para la investigación biomética Hospital Infantil Universitario Niño Jesús

PhaseNA
Planned participants42
Who can joinAll sexes, 3 Years to 8 Years
Healthy volunteersNo

About this study

The Guided Growth in Spastic Hip Multicenter Study (GGSH-MC) is a prospective, multicenter, randomized controlled trial that aims to evaluate the mid-term outcomes of Proximal Femoral Guided Growth (PFGG) in children with spastic cerebral palsy (CP) and hips at risk of dislocation (HRD). Hip dislocation is a common and severe complication in children with CP, especially those who are non-ambulatory, with a reported risk of 70-90%. The trial includes children aged 3 to 8 years with spastic CP and HRD, defined by a migration percentage (MP) between 30% and 60%. Participants will be cluster-randomized by center into two parallel groups: * Experimental Group: Standard prophylactic treatment for HRD + PFGG * Control Group: Standard prophylactic treatment for HRD only PFGG involves insertion of a fully threaded cannulated screw across the lateral cortex and proximal femoral epiphysis under fluoroscopic guidance, with the aim of modulating growth to improve hip containment. All patients will also receive standard soft tissue surgery (adductor and/or psoas tenotomies), as clinically indicated. Follow-up will include clinical, radiographic, and functional assessments at 3 and 6 weeks, and at 6, 12, 18, and 24 months post-intervention. The study will include a 1-year inclusion period and a 2-year follow-up, concluding in October 2027. Primary outcome measures include radiographic indicators of hip displacement. Secondary outcomes include functional scores, complication rates, and …

This description comes directly from the study's public registry record.

Talk to the study team

María Galán Olleros, M.D  ·  0034660492192  ·  mgalanolleros@gmail.com

Always discuss trial participation with your own doctor first.

Locations (16)

H. Materno Inf. Teresa HerreraA Coruña, A Coruña, SpainRecruiting
Hospital Universitario Torrecárdenas AlmeriaAlmería, Andalusia, SpainRecruiting
H.U. Virgen Macarena SevillaSeville, Andalusia, SpainRecruiting
H.U. Virgen Del RocioSeville, Andalusia, SpainRecruiting
Ihp-Orthopediatica SevillaSeville, Andalusia, SpainRecruiting
H. Universitari Son EspasesPalma, Balearic Islands, SpainRecruiting
H. Universitario de SalamancaSalamanca, Castille and León, SpainRecruiting
H. Sant Joan de DeuBarcelona, Catalonia, SpainRecruiting
Donostia University HospitalDonostia / San Sebastian, Gipuzkoa, SpainRecruiting
H. U. Gregorio MarañónMadrid, Madrid, SpainRecruiting
Hospital Infantil Universitario Niño JesúsMadrid, Madrid, SpainRecruiting
Hospital Universitario Ramón Y CajalMadrid, Madrid, SpainRecruiting

+ 4 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06956729